StockNews.com Initiates Coverage on Eagle Pharmaceuticals (N

Investment analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 2.5 % EGRX opened at $3.43 on Wednesday. The company’s 50-day moving […]

Related Keywords

United States , Los Angeles , California , , Eagle Pharmaceuticals Inc , Los Angeles Capital Management , News Ratings For Eagle Pharmaceuticals Daily , Eagle Pharmaceuticals , Eagle Pharmaceuticals Company Profile , Institutional Trading Of Eagle Pharmaceuticals , Eagle Pharmaceuticals Stock , Get Free Report , Investment Partners , Angeles Capital Management , Capital Partners , Financial Markets , Eagle Pharmaceuticals Daily ,